Forxiga 5mg Tablet

About

Forxiga 5mg Tablet contains dapagliflozin, an oral antidiabetic medication belonging to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. This medication works by blocking the reabsorption of glucose in the kidneys, leading to increased excretion of glucose in the urine. This mechanism effectively lowers blood glucose levels independently of insulin secretion. Beyond its glucose-lowering effects, dapagliflozin has demonstrated significant cardiovascular and renal benefits, making it a valuable treatment option for a broader range of patients. It has been shown to reduce the risk of cardiovascular death and hospitalization for heart failure, as well as slow the progression of chronic kidney disease. Forxiga is typically used as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus, and for its protective effects on the heart and kidneys in specific patient populations. Regular monitoring of kidney function and hydration status is important during treatment.

Uses

• To improve glycemic control in adults with Type 2 diabetes mellitus.
• To reduce the risk of cardiovascular death and hospitalization for heart failure.
• To reduce the risk of sustained eGFR decline, end-stage kidney disease, or renal death.
• As an adjunct to diet and exercise for blood sugar management.

Directions For Use

Take one tablet orally once daily, preferably in the morning, with or without food. Swallow the tablet whole with water.

Benefits

• Effectively lowers blood glucose levels.
• Reduces the risk of cardiovascular death.
• Slows the progression of chronic kidney disease.
• Contributes to modest weight loss.
• May help lower blood pressure.
• Reduces the risk of hospitalization for heart failure.

Side Effects

• Genital yeast infections (vulvovaginal candidiasis, balanitis)
• Urinary tract infections (UTIs)
• Increased urination (polyuria)
• Thirst
• Dizziness
• Hypotension (low blood pressure)
• Back pain
• Nausea
• Constipation
• Flu-like symptoms
• Diabetic ketoacidosis (rare but serious)
• Fournier's gangrene (very rare but serious)

Safety Measures

• Alcohol - Excessive alcohol consumption can increase the risk of dehydration and lactic acidosis. Use in moderation and stay well-hydrated.
• Pregnancy - Not recommended during the second and third trimesters due to potential adverse effects on fetal kidney development. Consult your doctor.
• Breastfeeding - Not recommended during breastfeeding due to potential for adverse effects in the infant. An alternative should be considered.
• Liver - No dose adjustment is needed for mild to moderate hepatic impairment. Use with caution in severe impairment.
• Kidney - Dose adjustment or contraindication based on eGFR. Not recommended for glycemic control if eGFR is below 45 mL/min/1.73m².
• Lung - No specific contraindications related to lung conditions. However, monitor for volume depletion, which could exacerbate respiratory issues in susceptible patients.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.